BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 30430284)

  • 21. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
    Ghinoi A; Mascia MT; Puccini R; Ferri C
    G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extrahepatic manifestations of HCV where do we stand?
    Mokhles MA
    Med Clin (Barc); 2024 Mar; 162(5):231-237. PubMed ID: 37980213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryoglobulinemia.
    Morra E
    Hematology Am Soc Hematol Educ Program; 2005; ():368-72. PubMed ID: 16304405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryoglobulins and pyroglobulins: an overview.
    Dammacco F; Miglietta A; Lobreglio G; Bonomo L
    Ric Clin Lab; 1986; 16(2):247-67. PubMed ID: 3097789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and incidence of cryoglobulins in hepatitis C virus-related chronic hepatitis patients: a prospective study.
    Persico M; De Marino FA; Di Giacomo Russo G; Persico E; Morante A; Palmentieri B; Torella R
    Am J Gastroenterol; 2003 Apr; 98(4):884-8. PubMed ID: 12738472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete remission of cryoglobulinemic glomerulonephritis (HCV-positive) after high dose interferon therapy.
    Laganović M; Jelaković B; Kuzmanić D; Sćukanec-Spoljar M; Roncević T; Cuzić S; Ostojić R
    Wien Klin Wochenschr; 2000 Jul; 112(13):596-600. PubMed ID: 10944819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro reactivity of cryoglobulin IgM and IgG in hepatitis C virus-associated mixed cryoglobulinemia.
    Schott P; Polzien F; Müller-Issberner A; Ramadori G; Hartmann H
    J Hepatol; 1998 Jan; 28(1):17-26. PubMed ID: 9537859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia.
    Cacoub P; Ghillani P; Revelen R; Thibault V; Calvez V; Charlotte F; Musset L; Youinou P; Piette JC
    J Hepatol; 1999 Oct; 31(4):598-603. PubMed ID: 10551381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cryoglobulinemia and chronic liver diseases].
    Csepregi A; Nemesánszky E; Bély M
    Z Gastroenterol; 1998 May; 36(5):391-401. PubMed ID: 9654707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characterization of cryoglobulin, M protein, low molecular weight IgM in a patient with chronic hepatitis C and type II mixed cryoglobulinemia].
    Nishiyama Y; Shimatsu A; Arakawa M; Nagao M; Saito A; Kido A; Koganeya H; Wada T; Okuda T; Ichiyama S
    Rinsho Byori; 2001 Nov; 49(11):1139-45. PubMed ID: 11769562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection.
    Sasso EH
    Ann Med Interne (Paris); 2000 Feb; 151(1):30-40. PubMed ID: 10761560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia.
    Agnello V; Abel G
    Arthritis Rheum; 1997 Nov; 40(11):2007-15. PubMed ID: 9365090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cryoglobulinemic vasculitis].
    Iusova OI; Krivosheev OG; Semenkova EN; Kogan EA
    Arkh Patol; 2000; 62(4):51-4. PubMed ID: 10971876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus (HCV) in cryoglobulinaemic leukocytoclastic vasculitis (LCV): could the presence of HCV in skin lesions be related to T CD8+ lymphocytes, HLA-DR and ICAM-1 expression?
    Bernacchi E; Civita LL; Caproni M; Zignego AL; Bianchi B; Monti M; Fabbri P; Pasero G; Ferri C
    Exp Dermatol; 1999 Dec; 8(6):480-6. PubMed ID: 10597137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent updates in the diagnosis and management of cryoglobulinemic vasculitis.
    Treppo E; Quartuccio L; De Vita S
    Expert Rev Clin Immunol; 2023; 19(12):1457-1467. PubMed ID: 37698547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurological manifestations of chronic hepatitis C.
    Heckmann JG; Kayser C; Heuss D; Manger B; Blum HE; Neundörfer B
    J Neurol; 1999 Jun; 246(6):486-91. PubMed ID: 10431776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience.
    Lauletta G; Russi S; Pavone F; Vacca A; Dammacco F
    Arthritis Res Ther; 2017 Apr; 19(1):74. PubMed ID: 28388935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus.
    D'Amico G; Fornasieri A
    Am J Kidney Dis; 1995 Mar; 25(3):361-9. PubMed ID: 7532915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryoglobulinemia.
    Winfield JB
    Hum Pathol; 1983 Apr; 14(4):350-4. PubMed ID: 6219936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?
    Bunchorntavakul C; Mitrani R; Reddy KR
    J Clin Exp Hepatol; 2018 Mar; 8(1):81-94. PubMed ID: 29743799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.